Contact
Please use this form to send email to PR contact of this press release:
EpiAxis Therapeutics, A Leader in Novel Cancer Therapy, Announces the Appointment of Three New Non-Executive Directors
TO:
Dr. Bill Mason
The Sage Group
+44 7785 950134